| Cell line name | KY-ADR1 |
|---|---|
| Accession | CVCL_Z939 |
| Resource Identification Initiative | To cite this cell line use: KY-ADR1 (RRID:CVCL_Z939) |
| Comments | Population: Japanese. Selected for resistance to: ChEBI; CHEBI:28680; Cytarabine (Arabinosylcytosine; Ara-C). Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin). Derived from site: In situ; Brain, meninges; UBERON=UBERON_0010743. |
| Disease | Acute myelomonocytic leukemia (NCIt: C7463) Acute myelomonocytic leukemia (ORDO: Orphanet_517) |
| Species of origin | Homo sapiens (Human) (NCBI Taxonomy: 9606) |
| Hierarchy | Parent: CVCL_W294 (KY-Ra) |
| Sex of cell | Male |
| Age at sampling | 28Y |
| Category | Cancer cell line |
| Publications | PubMed=7934146; DOI=10.1016/0145-2126(94)90071-X |
| Cross-references | |
| Encyclopedic resources | Wikidata; Q54900768 |
| Entry history | |
| Entry creation | 10-Apr-2015 |
| Last entry update | 29-Jun-2023 |
| Version number | 9 |